AT
Astria Therapeutics Inc
🇺🇸XNAS.ATXSUnited StatesHealthcare
$12.58USDup +0.02 (+0.16%)ClosedEnd of day11:32 PM
Price$12.58+0.02 (+0.16%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US04635X1028
- CUSIP
- 04635X102
Company
- Employees
- 78
- Headquarters
- Boston, United States
- Website
- https://www.astriatx.com
- CEO
- Ms. Jill C. Milne Ph.D.
Market
- Shares outstanding
- 57.1M
- Market cap
- $718.13M
Highlights
No high and low reported for today's session.
- Market cap
- $718.13M
- EPS LTM
- -$2.17calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -5.79calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $706K+100%up year on year
- Net income
- -$124.03M-23.98%down year on year
- Gross margin
- 100%
- Free cash flow
- -$120.32M-27.42%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.